 Consumer genetics company 23andMe ME, -3.29 posted its first quarterly earnings as a public company on Friday, after it merged with Richard Bransons pecial-purpose acquisition corporation, or SPAC, VG Acquisition Corp. in June. The company said it had a net loss of 42 million in its fiscal first quarter to June 20, wider than the loss of 36 million posted in the year-earlier period. 